RCBGX | VFICX | RCBGX / VFICX | |
Total Expense Ratio | 1.11 | 0.20 | 555% |
Annual Report Gross Expense Ratio | 1.12 | 0.20 | 560% |
Fund Existence | 9 years | 32 years | - |
Gain YTD | 1.642 | 1.636 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000 | 8% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.92B | 36.5B | 5% |
Annual Yield % from dividends | 3.46 | 4.66 | 74% |
Returns for 1 year | 2.11 | 0.58 | 365% |
Returns for 3 years | 6.52 | 1.10 | 594% |
Returns for 5 years | -11.52 | -17.77 | 65% |
Returns for 10 years | N/A | -0.74 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 27.58 | 0.20 | +0.74% |
Franklin Genomic Advancements ETF | |||
HIDV | 74.45 | 0.22 | +0.30% |
AB US High Dividend ETF | |||
ICLO | 25.67 | 0.03 | +0.10% |
Invesco AAA CLO Floating Rate Note ETF | |||
HECO | 33.20 | N/A | N/A |
SPDR Galaxy Hdg Dgtl Ast Ecosystem ETF | |||
NAC | 11.05 | -0.06 | -0.54% |
Nuveen California Quality Municipal Income Fund |